Product Description
Product Name: Dacarbazine Injection
Strength: 500 mg
Form: Lyophilized Powder for Intravenous Injection
Category: Antineoplastic / Alkylating Agent
Indication: Hodgkin’s Lymphoma, Malignant Melanoma, and Other Cancers as Directed
Dacarbazine 500 mg Injection is an alkylating chemotherapy agent used in the treatment of Hodgkin’s lymphoma (a type of cancer affecting the lymphatic system) and malignant melanoma (an aggressive form of skin cancer). It may also be prescribed for other malignancies, including soft tissue sarcomas or metastatic cancers, as determined by the treating physician.
